⌘K

Home/Filings/4/0001209191-24-003962

4//SEC Filing

Friedman Bart 4

Accession 0001209191-24-003962

CIK 0001636651other

View on SEC.gov Company Profile

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 5:57 PM ET

Size

5.4 KB

Accession

0001209191-24-003962

Insider Transaction Report

Form 4

Period: 2024-02-22

Ovid Therapeutics Inc.OVID

Director

Transactions

Award
Stock Option (Right to Buy)
2024-02-22+30,000→ 30,000 total
Exercise: $3.68Exp: 2034-02-21→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]The option will vest in full on February 22, 2025, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1

filerCIK 0001368324

Filing Metadata

Form type: 4
Filed: Feb 25, 7:00 PM ET
Accepted: Feb 26, 5:57 PM ET
Size: 5.4 KB

View on SEC.gov